Huntington, NY, United States of America

Ruiping Liu

USPTO Granted Patents = 10 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Huntington, NJ (US) (2008)
  • Huntington, NY (US) (2003 - 2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Ruiping Liu: Innovator in Phosphodiesterase 4 Inhibitors**

Introduction

Ruiping Liu is a notable inventor based in Huntington, NY, who has made significant contributions to the field of pharmaceuticals with a focus on phosphodiesterase 4 (PDE4) inhibitors. With an impressive portfolio of 10 patents, Liu's work aims to enhance the treatment options available for various conditions by developing selective inhibition techniques.

Latest Patents

Among her latest patents is the invention of selective PDE4 inhibition using 4-(substituted-phenyl)-2-pyrrolidinone compounds. These innovative compounds demonstrate improved PDE4 inhibition compared to previous treatments, such as rolipram, while maintaining selectivity towards other classes of PDEs. The compounds of her invention are characterized by a specific formula, with the specifics of R, R, and R defined within the patent documentation. Furthermore, her disclosure includes methods for preparing these compounds, compositions that incorporate them, and various methods of use.

Career Highlights

Ruiping Liu has contributed her expertise to several reputable companies, notably Memory Pharmaceuticals Corporation and 3-Dimensional Pharmaceuticals, Inc. Throughout her career, she has focused on advancing the pharmacological applications of her inventions, solidifying her status as an innovative force in the field.

Collaborations

Liu has collaborated with esteemed colleagues, including Allen T. Hopper and Ashok Tehim, further enhancing the breadth of her research and development efforts. These collaborations have played a significant role in the successful advancement of her patented technologies.

Conclusion

In summary, Ruiping Liu stands out as a pioneering inventor in the realm of phosphodiesterase 4 inhibitors. Her dedication to innovation and collaboration within prominent pharmaceutical companies underscores her impact on treatment methodologies. With a focus on selective PDE4 inhibition, Liu continues to pave the way for future advances in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…